Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

  • M. Shahmanesh*
  • , H. Jaleel
  • , Y. DeSilva
  • , J. D.C. Ross
  • , M. Caslake
  • , R. Cramb
    • *Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    6 Citations (SciVal)

    Fingerprint

    Dive into the research topics of 'Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology

    Pharmacology, Toxicology and Pharmaceutical Science